Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bac
TORONTO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., ("Arch" or the "Company") (TSXV:ARCH, OTCQB:ACHFF), announced today...
Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus
Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at...
AiCuris and Lysando Join Forces in the Fight Against Antimicrobial Resistance
Cooperation focused on the joint development and optimization of human anti-infective drug candidates against gram-negative and...
Understanding antibiotic resistance in patients with cystic fibrosis
A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis (CF). There, it traps bacteria,...